Direct Gene Correction Cures Severe Inherited Liver Disease in Groundbreaking Clinical Trial

Geneva, Tuesday, 3 November 2026.
A landmark clinical study confirms direct in vivo base editing successfully repaired mutated liver DNA at lowest doses with zero off-target edits, permanently restoring vital protective proteins without ongoing therapy.